Cancer Division Overview

A brief introduction to cancer-related research at Hull.

Research Strategy

The aim of cancer research in Hull is to improve both therapeutic options and quality of life for sufferers from solid tumours and leukaemia by:

• Studying the biology of cancers e.g. immunology, apoptosis and angiogenesis.
• Using novel techniques such as antibody microarrays and proteomics to identify novel biomarkers associated with anticancer therapy.
• Exploiting basic research findings to generate clinical hypotheses and testing them.
• Using imaging and radiotherapy to deliver targeted radiotherapy, radiotherapy combined with chemotherapy.
• Examining the role of psychological interventions in improving the quality of life in cancer patients and the functioning of their immune system (psychoneuroimmunology).
• Clinical Trials.

Facilities

Laboratory:

Daisy Research Laboratories, Castle Hill Hospital (cancer genetics, proteomics, immunohistochemistry, protein expression , DNA sequencing)

Medical Research Laboratory (immunology, flow cytometery)

Biomedical Research Laboratory

Clinical:

Oncology Clinical Trials office

Oncology Health Centres

Academic Surgical Unit

Dissemination

A monthly Cancer Biology Proteomics Group Seminar Series takes place at the Daisy Research Laboratories, Castle Hill Hospital. Work from the Group has been presented at international and national conferences.